PE HUB First Read
First Read begins the day with news that SoftBank takes control of WeWork as co-founder Neumann gets up to $1.7 billion to exit startup, Amazon declares war on dollar stores, and Aducanumab, the Alzheimer drug, may actually work.
First Read begins the day with news that SoftBank takes control of WeWork as co-founder Neumann gets up to $1.7 billion to exit startup, Amazon declares war on dollar stores, and Aducanumab, the Alzheimer drug, may actually work.